H.C. Wainwright analyst Douglas Tsao lowered the firm’s price target on Outlook Therapeutics (OTLK) to $3 from $30 and keeps a Buy rating on ...
NetScout Systems, Inc. is undervalued despite its strong positioning in network performance, cybersecurity, and cloud ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results